Unadjusted analysis | Adjusted model 1 | Adjusted model 2 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | ||||
Hospital case volume (vs. high) | ||||||||||||
Very low | 1.48 | 1.04 | 2.10 | 0.03 | 1.12 | 0.90 | 1.38 | 0.32 | 1.02 | 0.79 | 1.31 | 0.88 |
Low | 1.39 | 0.98 | 1.96 | 0.06 | 1.03 | 0.83 | 1.27 | 0.80 | 1.13 | 0.88 | 1.46 | 0.34 |
Medium | 1.32 | 0.92 | 1.90 | 0.13 | 1.06 | 0.85 | 1.33 | 0.59 | 1.03 | 0.80 | 1.32 | 0.83 |
Age (year) (vs. 55–64) | ||||||||||||
18–44 | 0.43 | 0.32 | 0.58 | <.001 | 0.48 | 0.35 | 0.67 | <.001 | ||||
45–54 | 1.24 | 0.96 | 1.61 | 0.10 | 1.30 | 0.98 | 1.73 | 0.07 | ||||
Charlson comorbidity index (vs. 0) | ||||||||||||
1 or 2 | 1.46 | 1.05 | 2.04 | 0.03 | 1.35 | 0.93 | 1.97 | 0.11 | ||||
3–6 | 3.00 | 2.03 | 4.43 | <.001 | 2.59 | 1.63 | 4.09 | <.001 | ||||
7 and above | 10.37 | 6.49 | 16.57 | <.001 | 11.04 | 6.25 | 19.49 | <.001 | ||||
Female (vs. male) | 1.63 | 1.24 | 2.15 | <.001 | 1.38 | 1.02 | 1.87 | 0.04 | ||||
Referred from clinics/other hospitals (vs. not) | 0.97 | 0.75 | 1.25 | 0.80 | 1.20 | 0.88 | 1.63 | 0.61 | ||||
Academic hospital (vs. non-academic) | 1.13 | 0.83 | 1.56 | 0.44 | 1.06 | 0.86 | 1.31 | 0.58 | ||||
Severity indices | ||||||||||||
BUN ≥21 mg/dL or signs of dehydration | 2.44 | 1.80 | 3.31 | <.001 | ||||||||
SpO2 ≤ 90% (or ≤ PaO2 60 Torr) | 2.26 | 1.61 | 3.16 | <.001 | ||||||||
Presence of cognitive disturbance | 5.85 | 4.18 | 8.18 | <.001 | ||||||||
Systolic blood pressure ≤90 mmHg | 2.83 | 1.97 | 4.07 | <.001 |